$179 Million is the total value of Sio Capital Management, LLC's 46 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACOR | New | ACORDA THERAPEUTICS INCput | $21,953,000 | – | 1,045,400 | +100.0% | 12.28% | – |
| SNY | New | SANOFI SAsponsored adr | $12,237,000 | – | 270,422 | +100.0% | 6.84% | – |
| BIIB | New | BIOGEN INC | $7,560,000 | – | 27,650 | +100.0% | 4.23% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $7,306,000 | – | 102,800 | +100.0% | 4.09% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $5,954,000 | – | 160,064 | +100.0% | 3.33% | – |
| MRK | New | MERCK & CO INCput | $5,083,000 | – | 80,000 | +100.0% | 2.84% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $4,608,000 | – | 30,000 | +100.0% | 2.58% | – |
| JNJ | New | JOHNSON & JOHNSONput | $3,737,000 | – | 30,000 | +100.0% | 2.09% | – |
| PFE | New | PFIZER INCput | $3,421,000 | – | 100,000 | +100.0% | 1.91% | – |
| MDT | New | MEDTRONIC PLC | $2,417,000 | – | 30,000 | +100.0% | 1.35% | – |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $2,389,000 | – | 77,244 | +100.0% | 1.34% | – |
| MOH | New | MOLINA HEALTHCARE INCcall | $2,280,000 | – | 50,000 | +100.0% | 1.28% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDUSTRIES LTDsponsored adr | $2,230,000 | – | 69,500 | +100.0% | 1.25% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $2,130,000 | – | 19,475 | +100.0% | 1.19% | – |
| GMED | New | GLOBUS MEDICAL INCcl a | $1,777,000 | – | 60,000 | +100.0% | 0.99% | – |
| Q | New | QUINTILES IMS HOLDINGS INCput | $1,731,000 | – | 21,500 | +100.0% | 0.97% | – |
| INSM | New | INSMED INCput | $1,488,000 | – | 85,000 | +100.0% | 0.83% | – |
| ITEK | New | INOTEK PHARMACEUTICALS CORP | $1,454,000 | – | 726,900 | +100.0% | 0.81% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $1,349,000 | – | 63,800 | +100.0% | 0.76% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $1,279,000 | – | 311,925 | +100.0% | 0.72% | – |
| VCRA | New | VOCERA COMMUNICATIONS INC | $1,238,000 | – | 49,871 | +100.0% | 0.69% | – |
| MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $937,000 | – | 31,465 | +100.0% | 0.52% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $885,000 | – | 91,413 | +100.0% | 0.50% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $819,000 | – | 210,000 | +100.0% | 0.46% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCput | $692,000 | – | 13,500 | +100.0% | 0.39% | – |
| NLNK | New | NEWLINK GENETICS CORP | $613,000 | – | 25,420 | +100.0% | 0.34% | – |
| PFNX | New | PFENEX INC | $499,000 | – | 85,867 | +100.0% | 0.28% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $142,000 | – | 333,712 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.